September 13, 2013

On Friday, UrgentRx, developer of fast-acting, over-the-counter flavored powder medications, announced Rick Hayward will be joining the company as the sales director for the food, drug and mass channels.

November 1, 2011

Drug maker Impax Labs reported sales of $119.8 million and profits of $20 million in third quarter 2011, according to an earnings report released Tuesday.

December 16, 2010

GlaxoSmithKline will pay Impax Pharmaceuticals $11.5 million upfront to exclusively sell Impax's investigational Parkinson’s disease treatment.